Clinical Trial Update: A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and pharmacokinetics of the P38 inhibitor PH-797804 in rheumatoid arthritis patients on methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PH-797804

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED